Peripheral artery disease: Latest News, Top Stories & Analysis

WAYNE, PA — Cagent Vascular has announced the enrollment of the first patient in its groundbreaking Serranator vs. POBA OCT Study. This innovative clinical trial aims to evaluate the benefits …

Strategic Combinations

Cagent Vascular Partners with 3comma Medical to Expand Global Reach

April 8, 2025April 7, 2025 - by Timothy Alexander

WAYNE, PA — Cagent Vascular, Inc. has announced a strategic partnership with 3comma Medical GmbH to accelerate the international adoption of the Serranator® PTA Serration Balloon Product Family. Through this …